Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Bolus Insulin, Glucose Monitoring, Insulin Delivery, SGLT2i, Topics Mar 09 | 2018JPM Day 2: Sanofi, Lilly, Lexicon, Dexcom and morePurchase Blast
$599
Posted in: Basal Insulin, Topics Feb 21 | 2018Biocon Malaysian facility receives six form 483 observations from FDAPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Feb 21 | 2018CGM thoughts: Senseonics vs. Dexcom and AbbottPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Topics Feb 15 | 2018Dexcom displays representation of Lilly connected insulin penPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Feb 14 | 2018Glooko insulin titration app FDA clearedPurchase Blast
$599
Feb 08 | 2018Novo Nordisk Launches Rebinyn in the US for People with Hemophilia BPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Feb 06 | 2018Abbott FreeStyle Libre to utilize Apple's NFC technologyPurchase Blast
$599
Posted in: DPP-IVi, GLP-1RA, SGLT2i, Topics Feb 02 | 2018AZ Q4 '17 Earnings UpdatePurchase Blast
$599
Posted in: SGLT2i, Topics Jan 30 | 2018Jardiance outcomes-based contract with Prime TherapeuticsPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Topics Jan 26 | 2018JDRF partners with Korean patch pump manufacturerPurchase Blast
$599
Posted in: Basal Insulin, Topics Jan 25 | 2018Biocon CY Q4 ’17 (FY Q3 ’18) Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, SGLT2i, Topics Jan 23 | 2018J&J Q4 '17 Earnings UpdatePurchase Blast